KRT18 and breast cancer: For example, serum M30 and M65 levels were ineffective for predicting neoadjuvant chemotherapy responses in patients with breast cancer, and obstructive jaundice in addition to prolonged plasma placement interfered with baseline K18 levels in patients with pancreatic cancer (160, 161).